Form 4: Alignment Healthcare Executive Hakan Kardes Acquires Shares Through PSU Vesting, Sells to Cover Taxes

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, acquired 474,208 shares of common stock through the vesting of performance share units (PSUs) and subsequently sold 86,659 shares to cover tax obligations.

Summary

• On March 4, 2025, Hakan Kardes, Chief Experience Officer of Alignment Healthcare, acquired 474,208 shares of common stock due to the vesting of performance share units (PSUs).
• The PSUs were granted on September 14, 2023, and vested based on the achievement of certain performance objectives related to health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA less capital expenditures.
• The performance objectives were achieved above target.
• Fifty percent of the granted PSUs vested on March 4, 2025, and the remaining fifty percent will vest on December 31, 2025, contingent upon continued service.
• On March 6, 2025, Kardes sold 86,659 shares of common stock at a weighted-average price of $15.53 per share, with individual sales ranging from $15.12 to $16.065, to cover tax withholding obligations related to the PSU vesting.
• Following these transactions, Kardes directly owns 682,993 shares of Alignment Healthcare common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The vesting of PSUs suggests the company is meeting its performance goals. The sale of shares to cover taxes is a neutral event.

Positives

• The vesting of PSUs indicates that Alignment Healthcare achieved its performance objectives above target, suggesting positive performance.

Negatives

• The sale of shares to cover tax obligations, while not a discretionary trade, could be perceived negatively by some investors.

Risks

• Future vesting of the remaining 50% of the PSUs is contingent upon the reporting person's continued service to the company, creating a potential risk if the reporting person leaves the company before the vesting date.

Future Outlook

Fifty percent of the granted PSUs will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Industry Context

Executive stock transactions are common in the healthcare industry as part of compensation packages. Vesting of performance-based equity indicates achievement of company goals, which is generally viewed positively. Sales to cover tax obligations are also typical and don't necessarily reflect a negative outlook on the company's future.

Comparison to Industry Standards

• Comparing Alignment Healthcare's executive compensation structure to peers like Humana, UnitedHealth Group, or CVS Health, it's common to see a mix of salary, bonus, and equity-based compensation.
• The use of PSUs tied to specific performance metrics is a standard practice to align executive incentives with shareholder value creation.
• The vesting schedules and performance targets are usually benchmarked against industry averages to ensure competitiveness and effectiveness.

Stakeholder Impact

• Shareholders may view the PSU vesting positively as it indicates the company is achieving its performance targets.
• Employees may be motivated by the achievement of performance objectives tied to executive compensation.

Key Dates